Search results
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next...
Pharmaceutical Technology via Yahoo Finance· 1 hour agoSouth Africa’s existing regulatory, consent and ethics frameworks around HIV vaccine trial investigations helped with regards to quick initiation and straightforward progress of COVID-19 vaccine trials in the country, the source said.
Eli Lilly Runs Up 49% With Expectations For Weight-Loss Sales To Triple
Investor's Business Daily· 6 days agoRevenue from Eli Lilly's weight-loss drug is expected to triple over the next five years to over $50...
Lilly’s Phase II results in Alzheimer’s disease have most experts saying donanemab is done
Clinical Trials Arena via Yahoo Finance· 1 day agoEli Lilly’s donanemab for early symptomatic Alzheimer’s disease (AD) has most experts dubious of the...
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias...
WTNH-TV New Haven· 4 days agoStarting from molecular design, the unique approach of α bias with β and γ attenuated were...
FDA halts trial of BioNTech-MediLink ADC over 'significant risk of illness'
FierceBiotech· 22 hours agoThe FDA has slammed the brakes on a trial of MediLink Therapeutics’ BioNTech-partnered antibody-drug...
100 Ways To Make Money Without a Job
GOBankingRates via Yahoo Finance· 6 days agoIf you want to make money outside of a 9-to-5 job, then you should take a look at these 100 ways to score some income without having a traditional job.
Izokibep Marches on for Psoriatic Arthritis
MedPage Today· 2 days agoAfter 16 weeks of treatment in the randomized, placebo-controlled study, 40% and 43% of patients receiving 160 mg of izokibep weekly or biweekly,...
Early data for Avidity's RNA therapy show possible functional benefit in muscular dystrophy
FierceBiotech· 6 days agoAvidity Biosciences’ AOC 1020, newly dubbed del-brax, demonstrated a safe profile and was tied to...
New EHA data reveal how badly Gilead's $4.9B bet on CD47 imploded
FierceBiotech· 4 days agoGilead Sciences' abandoned anti-CD47 drug magrolimab was not just ineffective, but could potentially...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Digital Journal· 5 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and olderHigher efficacy was observed in mRNA-1283 compared